Showing 1 to 11 of 11 results


Moderna Defends UK Drug Pricing Amid Industry Criticism
Moderna opened a \£150 million vaccine facility in Oxfordshire, defending the UK's drug pricing system after criticism from other pharmaceutical companies who have paused investments due to pricing disputes with the government.
Moderna Defends UK Drug Pricing Amid Industry Criticism
Moderna opened a \£150 million vaccine facility in Oxfordshire, defending the UK's drug pricing system after criticism from other pharmaceutical companies who have paused investments due to pricing disputes with the government.
Progress
32% Bias Score


Five Years of "Sputnik V": A COVID-19 Vaccine's Impact on Global Health
Sputnik V," Russia's adenovirus-based COVID-19 vaccine, registered five years ago on August 11, 2025, achieved over 90% efficacy in clinical trials, saving tens of thousands of lives and influencing global vaccine development, despite initial skepticism and reduced effectiveness against later Omicro...
Five Years of "Sputnik V": A COVID-19 Vaccine's Impact on Global Health
Sputnik V," Russia's adenovirus-based COVID-19 vaccine, registered five years ago on August 11, 2025, achieved over 90% efficacy in clinical trials, saving tens of thousands of lives and influencing global vaccine development, despite initial skepticism and reduced effectiveness against later Omicro...
Progress
60% Bias Score


Universal Cancer Vaccine Shows Promise in Mice Studies
A new mRNA-based cancer vaccine, tested on mice with various cancers, demonstrates potential as a universal treatment, shrinking or eliminating tumors when combined with immunotherapy, improving survival rates significantly; however, human trials are still needed.
Universal Cancer Vaccine Shows Promise in Mice Studies
A new mRNA-based cancer vaccine, tested on mice with various cancers, demonstrates potential as a universal treatment, shrinking or eliminating tumors when combined with immunotherapy, improving survival rates significantly; however, human trials are still needed.
Progress
52% Bias Score


mRNA Covid Vaccines and Cancer: Examining the Evidence
Despite some doctors reporting increased aggressive cancers after mRNA Covid vaccine rollout, global medical consensus and data from regulatory bodies like the MHRA show no conclusive evidence linking them; pre-existing cancer trends and the lack of localized cancers near injection sites also weaken...
mRNA Covid Vaccines and Cancer: Examining the Evidence
Despite some doctors reporting increased aggressive cancers after mRNA Covid vaccine rollout, global medical consensus and data from regulatory bodies like the MHRA show no conclusive evidence linking them; pre-existing cancer trends and the lack of localized cancers near injection sites also weaken...
Progress
16% Bias Score


Trump Launches \$500 Billion AI Project to Cure Cancer
President Trump launched Project Stargate, a \$500 billion AI-driven initiative to develop personalized mRNA cancer vaccines, aiming to detect and treat early-stage cancers through AI-powered blood tests and rapid vaccine production within 48 hours, despite concerns about public and political resist...
Trump Launches \$500 Billion AI Project to Cure Cancer
President Trump launched Project Stargate, a \$500 billion AI-driven initiative to develop personalized mRNA cancer vaccines, aiming to detect and treat early-stage cancers through AI-powered blood tests and rapid vaccine production within 48 hours, despite concerns about public and political resist...
Progress
52% Bias Score


US H5N1 Outbreak Prompts State of Emergency, Fuels Vaccine Research
Over 60 human H5N1 infections and 123 million poultry infections across the US have prompted a state of emergency in California and highlight the need for new vaccine technologies to combat potential human-to-human transmission.
US H5N1 Outbreak Prompts State of Emergency, Fuels Vaccine Research
Over 60 human H5N1 infections and 123 million poultry infections across the US have prompted a state of emergency in California and highlight the need for new vaccine technologies to combat potential human-to-human transmission.
Progress
28% Bias Score

Kennedy's Decision to Halt mRNA Research Funding Threatens Future Medical Advancements
President Trump's Operation Warp Speed initiative rapidly developed mRNA COVID-19 vaccines, saving millions of lives; however, Secretary Kennedy's decision to end federal mRNA research funding threatens future medical advancements and pandemic preparedness.

Kennedy's Decision to Halt mRNA Research Funding Threatens Future Medical Advancements
President Trump's Operation Warp Speed initiative rapidly developed mRNA COVID-19 vaccines, saving millions of lives; however, Secretary Kennedy's decision to end federal mRNA research funding threatens future medical advancements and pandemic preparedness.
Progress
60% Bias Score

HHS Cancels $500 Million in mRNA Vaccine Contracts
HHS Secretary Robert F. Kennedy Jr. announced the cancellation of nearly $500 million in mRNA vaccine development contracts, impacting 22 projects and several companies, citing ineffectiveness against upper respiratory infections and shifting funding toward alternative vaccine platforms; this decisi...

HHS Cancels $500 Million in mRNA Vaccine Contracts
HHS Secretary Robert F. Kennedy Jr. announced the cancellation of nearly $500 million in mRNA vaccine development contracts, impacting 22 projects and several companies, citing ineffectiveness against upper respiratory infections and shifting funding toward alternative vaccine platforms; this decisi...
Progress
56% Bias Score

Trump Administration Cancels $766 Million Moderna Flu Vaccine Contract
The Trump administration cancelled two Moderna contracts worth $766 million for H5N1 bird flu vaccines following positive trial results, citing insufficient testing of mRNA technology, despite a prior US bird flu outbreak resulting in one death.

Trump Administration Cancels $766 Million Moderna Flu Vaccine Contract
The Trump administration cancelled two Moderna contracts worth $766 million for H5N1 bird flu vaccines following positive trial results, citing insufficient testing of mRNA technology, despite a prior US bird flu outbreak resulting in one death.
Progress
44% Bias Score

Russia to Launch Personalized mRNA Cancer Vaccine in September 2025
Russia will introduce a personalized mRNA cancer vaccine for melanoma and some leukemia patients in September 2025, developed by the Gamaleya Research Institute with funding from President Putin; initial trials show promise.

Russia to Launch Personalized mRNA Cancer Vaccine in September 2025
Russia will introduce a personalized mRNA cancer vaccine for melanoma and some leukemia patients in September 2025, developed by the Gamaleya Research Institute with funding from President Putin; initial trials show promise.
Progress
64% Bias Score

U.S. Invests $766 Million in mRNA Bird Flu Vaccine Amid Growing Pandemic Fears
The U.S. government is investing $766 million in Moderna to develop an mRNA bird flu vaccine due to the virus spreading to dairy cows and causing 67 human infections (one death), despite the CDC stating low public risk; the mRNA vaccine offers faster production than traditional methods.

U.S. Invests $766 Million in mRNA Bird Flu Vaccine Amid Growing Pandemic Fears
The U.S. government is investing $766 million in Moderna to develop an mRNA bird flu vaccine due to the virus spreading to dairy cows and causing 67 human infections (one death), despite the CDC stating low public risk; the mRNA vaccine offers faster production than traditional methods.
Progress
52% Bias Score
Showing 1 to 11 of 11 results